- Smith & Nephew (NYSE:SNN) announces the European launch of MolecuLight i:X, a handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of harmful bacteria in wounds.
- The company says MolecuLight i:X enhances a clinician’s ability to choose the right therapy, at the right time and can help to guide wound sampling and debridement.
- Clinical data from wound assessments demonstrates that incorporating the MolecuLight i:X into standard care facilitated more objective medical decision making and led to up to 9 times faster wound healing and 54% more accurate swabbing.
- The MolecuLight i:X Imaging Device is approved by Health Canada and has CE Marking for sale in the European Union. The MolecuLight i:X Imaging Device is not available in the US.